Respiratory illness trial boosts Cynata share price today
MELBOURNE: Shares in stem cell biotech Cynata Therapeutics have jumped 4.3 per cent, ...
To read the full story...SUBSCRIBE NOWExisting Subscribers Login Below:
Log In
